The Traderszone Network

Published in TZ Latest News 28 November, 2014 by The TZ Newswire Staff

Newly Profitable Medivation Riding High On Drug Sales

Biopharmaceutical company Medivation (MDVN) recently turned profitable in a big way. The company — a new entrant to the IBD Stock Spotlight screen — focuses on developing therapies to treat serious illnesses for which few treatment options exist. On Nov. 6, Medivation reported third-quarter earnings of 96 cents a share compared with a loss in the year-earlier period. Sales growth accelerated for a second straight quarter to a 234% gain.

read more